Literature DB >> 2985509

Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs.

A Schneider, H Kraus, R Schuhmann, L Gissmann.   

Abstract

A total of 311 smears from the lower genital tract were examined by the filter in situ hybridization method to identify human papillomavirus (HPV) DNA. Of these 311 smears, 229 came from clinically and cytologically negative patients and served as a control group. In this group HPV-DNA was detected in 5 cases (2.2%). Of 82 cytologically positive cases (25 confirmed by histology) 56 (68%) contained HPV-DNA. A high prevalence of HPV 6/11 and absence of HPV 16/18 was found in cases with cytological signs of permissive HPV infection. In mild and moderate dysplasia all viruses occurred at almost the same frequency. In severe dysplasia/carcinoma in situ HPV 16/18 was found 5 times more frequently than HPV 6/11. HPV 16/18 was identified in all 4 invasive cancer cases. Cervical irrigation of colposcopically suspect areas was performed in 15 cytologically and HPV-DNA positive cases using the hydrodynamic filtration method. In 12 cases only the cells obtained from the colposcopically positive areas contained HPV-DNA. The sensitivity and reproducibility of the filter in situ hybridization was shown by: comparing the results obtained by HPV-DNA hybridization using Southern blot analysis of tumor biopsies; analysing the correlation of cytologic diagnosis and presence of HPV-DNA in follow-up examinations, and diagnosing presence or absence of HPV-DNA in parallel filters from the same patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985509     DOI: 10.1002/ijc.2910350405

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Detection of DNA of human papillomavirus types 6/11 and 16/18 in cell scrapings of the uterine cervix by filter in situ hybridisation. Correlation with cytology, colposcopy and histology.

Authors:  T Demeter; J K Kulski; G F Sterrett; E C Pixley
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

2.  Occurrence of HPV genomes in penile smears of healthy men.

Authors:  E I Grussendorf-Conen; W Meinhof; E M de Villiers; L Gissmann
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Routine papillomavirus antigen staining of cervical punch biopsy specimens.

Authors:  D Jenkins; S K Tay; P H Maddox
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

Review 4.  Role of papillomaviruses.

Authors:  F Chang
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

5.  An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model.

Authors:  D M Parkin; S M Moss
Journal:  J Epidemiol Community Health       Date:  1986-06       Impact factor: 3.710

6.  Transforming activity of human papillomavirus type 16 DNA sequence in a cervical cancer.

Authors:  Y Tsunokawa; N Takebe; T Kasamatsu; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.

Authors:  L S Young; I S Bevan; M A Johnson; P I Blomfield; T Bromidge; N J Maitland; C B Woodman
Journal:  BMJ       Date:  1989-01-07

Review 8.  Human papillomaviruses: are we ready to type?

Authors:  A Roman; K H Fife
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

9.  Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction.

Authors:  G J Nuovo; M M Darfler; C C Impraim; S E Bromley
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

10.  Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results.

Authors:  G Veress; T Csiky-Mészáros; J Czeglédy; L Gergely
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.